TL;DR
This study reveals that while the global burden of adult pertussis has generally declined since 1990, there was a concerning resurgence between 2009 and 2019, particularly in lower-income regions and specific adult age groups. The COVID-19 pandemic caused a dramatic, albeit temporary, drop in cases, highlighting the impact of public health interventions and the need for targeted adult vaccination strategies.
What Problem Does This Paper Address?
Pertussis, commonly known as whooping cough, has historically been viewed as a childhood illness due to its severe manifestations and high mortality rates in infants. However, recent decades have seen a paradoxical resurgence of pertussis, with increasing cases reported in adults across various regions. This shift is attributed to waning immunity from childhood vaccinations, potential evolutionary changes in the Bordetella pertussis bacterium, and improved diagnostic capabilities that allow for better detection in adults who often present with milder or atypical symptoms. This study aims to systematically quantify the global burden of pertussis specifically in adults (aged 20 and above), analyze age-specific trends, and assess the impact of the COVID-19 pandemic on these trends, filling a gap in understanding the disease's adult burden.
Methods
The researchers utilized data from the Global Burden of Disease (GBD) Study 2021, a comprehensive source for global health metrics. They analyzed incidence rates and disability-adjusted life years (DALYs) for adults aged 20 and older, stratified by age, sex, and sociodemographic factors (using the Sociodemographic Index - SDI) and geographic regions (World Bank regions).
To analyze temporal trends and detect significant changes, they employed joinpoint regression analysis. This method identifies "joinpoints" where the trend in incidence or DALYs changes significantly, allowing for the calculation of annual percentage change (APC) for each segment. The overall trend across longer periods was summarized by the Annual Average Percentage Change (AAPC).
To estimate the impact of the COVID-19 pandemic, an exponential smoothing state-space model (ETS) was used to forecast pertussis cases for 2020 and 2021 based on pre-pandemic data. These forecasts were then compared to the observed data to quantify the reduction in incidence and DALYs attributed to pandemic-related public health and social measures (PHSMs).
Datasets
The primary dataset used in this study was the Global Burden of Disease (GBD) Study 2021 data. This dataset provides comprehensive estimates for 371 diseases and injuries across 204 countries and territories from 1990 to 2021. The study did not introduce new benchmark datasets.
Key Insights and Ideas
- Adults are not immune: The study strongly reinforces that pertussis is a significant health concern for adults, not just children, due to waning immunity and improved detection.
- The "resurgence" is real and complex: While overall global trends show a decline, specific periods and regions experienced a worrying increase in adult pertussis, indicating that the disease is not fully controlled.
- COVID-19's unexpected impact: The dramatic drop in pertussis cases during the pandemic underscores the effectiveness of public health interventions like social distancing and mask-wearing in interrupting transmission.
- Socioeconomic disparities matter: The burden of pertussis is disproportionately higher in low-SDI countries, highlighting the need for targeted interventions in these regions.
- Age is a critical factor: Specific adult age groups are more vulnerable, suggesting that current vaccination strategies may need to be re-evaluated for adult populations.
Key Results
- Global Decline with Fluctuations: The global incidence rate of adult pertussis declined from 17.44 per 100,000 in 1990 to 9.00 per 100,000 in 2019, and then sharply to 2.70 per 100,000 by 2021. DALY rates followed a similar trend.
- Resurgence (2009-2019): Despite the overall decline, incidence rates increased in 84 countries between 2009 and 2019. The number of cases also increased in low-SDI countries during this period.
- SDI Disparities: In 2019, the incidence rate in low-SDI countries (18.59 per 100,000) was over four times higher than in high-SDI countries (3.96 per 100,000).
- COVID-19 Impact: The pandemic led to an estimated 58.41% reduction in incidence and a 50.34% decrease in DALYs in 2020-2021 compared to forecasts. This reduction was most pronounced in adults aged 55 and older.
- Age-Specific Trends: While incidence declined in younger adults, there was an increase in case numbers between 2009 and 2019 for older adult groups (45-49, 50-54, and ≥55 years).
Limitations and Future Work
The authors acknowledge several limitations:
- Model-Based Estimates: GBD estimates rely on mathematical modeling, which is sensitive to assumptions, data quality, and completeness. Adult pertussis is notoriously difficult to diagnose, leading to potential underestimation even with GBD adjustments.
- Data Granularity: The study lacked detailed data on crucial covariates such as specific adult booster vaccination coverage, types of vaccines used, timing of transitions, country-specific control measures, and pathogen strain characteristics.
- Surveillance System Changes: Over the long study period, changes in pertussis case definitions or surveillance system sensitivity in various countries could have affected data consistency.
- COVID-19 Long-Term Impact: The full long-term impact of the COVID-19 pandemic on pertussis epidemiology, including potential shifts in immunity and healthcare-seeking behaviors, is yet to be fully understood.
Future work should aim to:
- Incorporate and quantify the effects of the identified limitations.
- Conduct more thorough quantitative analyses using additional data on covariates.
- Continue research to understand the complex, long-term effects of the COVID-19 pandemic on pertussis.
- Emphasize the need for targeted vaccination programs and robust surveillance systems for adults, particularly in resource-constrained settings.
Summary updated